Primary Site >> Colorectal Cancer
Gene >> MET
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Defective posttranslational processing activates the tyrosine kinase encoded by the MET proto-oncogene (hepatocyte growth factor receptor). PMID: 1658624 Ref: The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors. PMID: 1917129 |
Ref: Frequent amplification of the c-met gene in scirrhous type stomach cancer. PMID: 1333188 Ref: Overexpression of c-met proto-oncogene but not epidermal growth factor receptor or c-erbB-2 in primary human colorectal carcinomas. PMID: 1741162 |
Ref: [Metastasis related genes and malignancy in human esophageal, gastric and colorectal cancers]. PMID: 8094950 Ref: Signal transduction in c-met mediated motogenesis. PMID: 8380734 Ref: Regulation of spreading and growth of colon cancer cells by hepatocyte growth factor. PMID: 8386069 Ref: Molecular mechanism of stomach carcinogenesis. PMID: 8440743 |
Ref: [Metastasis-related genes]. PMID: 7526801 Ref: Accelerated growth of human colon cancer cells in nude mice undergoing liver regeneration. PMID: 7657529 Ref: Hepatocyte growth factor stimulates invasion across reconstituted basement membranes by a new human small intestinal cell line. PMID: 8306528 |
Ref: Genetic alterations in human gastrointestinal cancers. The application to molecular diagnosis. PMID: 7889467 Ref: Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic programs in epithelial cells. PMID: 8522613 Ref: Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer. PMID: 9815967 |
Ref: [Prognostic factors of colon cancer from a molecular biology standpoint]. PMID: 8687233 Ref: [Expression of hepatocyte growth factor and its receptor, C-Met in human digestive tissues and different gastric and colonic cancer cell lines]. PMID: 8761141 Ref: Regulation of expression of the hepatocyte growth factor scatter factor receptor, c-met, by cytokines. PMID: 21594411 |
Ref: Progression of familial adenomatous polyposis (FAP) colonic cells after transfer of the src or polyoma middle T oncogenes: cooperation between src and HGF/Met in invasion. PMID: 9010033 Ref: Influence of the host microenvironment on the clonal selection of human colon carcinoma cells during primary tumor growth and metastasis. PMID: 9062390 Ref: Genetic alterations in gastric cancer: relation to histological subtypes, tumor stage, and Helicobacter pylori infection. PMID: 9136822 Ref: Expression of the HGF/SF receptor, c-met, and its ligand in human colorectal cancers. PMID: 9412656 Ref: Expression of c-met proto-oncogene in primary colorectal cancer and liver metastases. PMID: 9437998 Ref: Activation of c-Src by receptor tyrosine kinases in human colon cancer cells with high metastatic potential. PMID: 9444956 |
Ref: [The expression of cMET/hepatocyte growth factor receptor in colorectal cancer]. PMID: 9721515 Ref: Hepatocyte growth factor/scatter factor induces not only scattering but also cohort migration of human colorectal-adenocarcinoma cells. PMID: 9833769 |
Ref: Hepatocellular carcinoma cell lines from diethylnitrosamine phenobarbital-treated rats. Characterization and sensitivity to endothall, a protein serine/threonine phosphatase-2A inhibitor. PMID: 10216123 Ref: Clinical significance of c-met oncogene alterations in human colorectal cancer. PMID: 10343196 Ref: Association of the HGF/SF receptor, c-met, with the cell-surface adhesion molecule, E-cadherin, and catenins in human tumor cells. PMID: 10425198 Ref: CD44 stimulation induces integrin-mediated adhesion of colon cancer cell lines to endothelial cells by up-regulation of integrins and c-Met and activation of integrins. PMID: 10485493 |
Ref: Nk4, a new HGF/SF variant, is an antagonist to the influence of HGF/SF on the motility and invasion of colon cancer cells. PMID: 10699931 Ref: Functional expression of HGF and its receptor in human colorectal cancer. PMID: 10878450 Ref: Met/HGF receptor modulates bcl-w expression and inhibits apoptosis in human colorectal cancers. PMID: 10944610 Ref: Expression of hepatocyte growth factor and c-met in ulcerative colitis. PMID: 10959552 Ref: Expression of c-Met and heparan-sulfate proteoglycan forms of CD44 in colorectal cancer. PMID: 11073815 Ref: In vivo and in vitro interactions between human colon carcinoma cells and hepatic stellate cells. PMID: 11123428 Ref: The coordinated functional expression of epidermal growth factor receptor and c-Met in colorectal carcinoma metastasis. PMID: 11125542 Ref: Experimental and clinicopathologic studies on the function of the HGF receptor in human colon cancer metastasis. PMID: 11827067 |
Ref: HGF upregulates and modifies subcellular distribution of proteins in colon cancer cell enterocytic differentiation. PMID: 11557528 |
Ref: Hepatocyte growth factor levels in liver and blood, and post-operative liver cell proliferation in patients with benign and malignant liver tumors after partial hepatectomy. PMID: 12388921 Ref: The use of molecular profiling of early colorectal cancer to predict micrometastases. PMID: 12470104 Ref: [Report on the first year of the activity of the National Oncological RD Consortium]. PMID: 12563351 |
Ref: Clinicopathologic characteristics and prognoses of gastric cancer in patients with a positive familial history of cancer. PMID: 12488704 Ref: c-MET expression level in primary colon cancer: a predictor of tumor invasion and lymph node metastases. PMID: 12684423 Ref: Down-regulation of c-Met inhibits growth in the liver of human colorectal carcinoma cells. PMID: 12782608 Ref: Activation of c-Met in colorectal carcinoma cells leads to constitutive association of tyrosine-phosphorylated beta-catenin. PMID: 12856716 Ref: Prostaglandins promote colon cancer cell invasion; signaling by cross-talk between two distinct growth factor receptors. PMID: 12958170 |
Ref: HGF and ligation of alphavbeta5 integrin induce a novel, cancer cell-specific gene expression required for cell scattering. PMID: 14697335 Ref: Hepatic gene expression of NK4, an HGF-antagonist/angiogenesis inhibitor, suppresses liver metastasis and invasive growth of colon cancer in mice. PMID: 15017381 Ref: Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac. PMID: 15059978 Ref: [Report of the National Oncology Research and Developement Consortium, 2003]. PMID: 15105900 Ref: Immunohistochemical expression of HGF, c-MET and transcription factor STAT3 in colorectal tumors. PMID: 15590419 Ref: Immunoblot analysis of c-Met expression in human colorectal cancer: overexpression is associated with advanced stage cancer. PMID: 15672865 |
Ref: Novel potent orally active selective VEGFR-2 tyrosine kinase inhibitors: synthesis, structure-activity relationships, and antitumor activities of N-phenyl-N'-{4-(4-quinolyloxy)phenyl}ureas. PMID: 15743179 Ref: Insulinlike growth factor-I-mediated migration and invasion of human colon carcinoma cells requires activation of c-Met and urokinase plasminogen activator receptor. PMID: 15849510 Ref: [Effect of HAI-1 over-expression on in vitro growth and migration/motility of SW620 cells]. PMID: 16044910 Ref: Lysophosphatidic acid transactivates both c-Met and epidermal growth factor receptor, and induces cyclooxygenase-2 expression in human colon cancer LoVo cells. PMID: 16237757 Ref: X-Linked inhibitor of apoptosis protein expression level in colorectal cancer is regulated by hepatocyte growth factor/C-met pathway via Akt signaling. PMID: 16278380 |
Ref: Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer. PMID: 16158056 Ref: Peanut lectin stimulates proliferation of colon cancer cells by interaction with glycosylated CD44v6 isoforms and consequential activation of c-Met and MAPK: functional implications for disease-associated glycosylation changes. PMID: 16571666 Ref: Hepatocyte growth factor installs a survival platform for colorectal cancer cell invasive growth and overcomes p38 MAPK-mediated apoptosis. PMID: 16677802 Ref: [Insulin-like growth factor receptor, hepatocyte-derived growth factor receptor and telomerase expression in ulcerative colitis]. PMID: 17066600 |
Ref: Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome. PMID: 16945480 Ref: A positive feedback loop between hepatocyte growth factor receptor and beta-catenin sustains colorectal cancer cell invasive growth. PMID: 16953230 Ref: Inducing effects of hepatocyte growth factor on the expression of vascular endothelial growth factor in human colorectal carcinoma cells through MEK and PI3K signaling pathways. PMID: 17531111 Ref: Quantification of MET and hepatocyte growth factor/scatter factor expression in colorectal adenomas, carcinomas and non-neoplastic epithelia by quantitative laser scanning microscopy. PMID: 17549422 Ref: Activation of Src by c-Met overexpression mediates metastatic properties of colorectal carcinoma cells. PMID: 17552361 Ref: Blocking heat shock protein-90 inhibits the invasive properties and hepatic growth of human colon cancer cells and improves the efficacy of oxaliplatin in p53-deficient colon cancer tumors in vivo. PMID: 18025273 |
Ref: hTERT-targeted RNA interference inhibits tumorigenicity and motility of HCT116 cells. PMID: 18059183 Ref: Gab1 but not Grb2 mediates tumor progression in Met overexpressing colorectal cancer cells. PMID: 18192688 Ref: Cell growth, global phosphotyrosine elevation, and c-Met phosphorylation through Src family kinases in colorectal cancer cells. PMID: 18258742 Ref: Cyclooxygenase-2 inhibition inhibits c-Met kinase activity and Wnt activity in colon cancer. PMID: 18281498 Ref: c-Met gene amplification is associated with advanced stage colorectal cancer and liver metastases. PMID: 18395971 Ref: The relative distribution of membranous and cytoplasmic met is a prognostic indicator in stage I and II colon cancer. PMID: 18559601 Ref: Elevated insulin-like growth factor 1 receptor, hepatocyte growth factor receptor and telomerase protein expression in mild ulcerative colitis. PMID: 18938767 Ref: Prognostic relevance of occult nodal micrometastases and circulating tumor cells in colorectal cancer in a prospective multicenter trial. PMID: 19010855 Ref: c-Met expression in primary tumors and their corresponding distant metastases. PMID: 21479486 |
Ref: MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. PMID: 19098908 Ref: Resistance to EGF-R (erbB-1) and VEGF-R modulating agents. PMID: 19124237 Ref: NK4, an HGF antagonist, prevents hematogenous pulmonary metastasis by inhibiting adhesion of CT26 cells to endothelial cells. PMID: 19234748 Ref: Overexpression of MACC1 leads to downstream activation of HGF/MET and potentiates metastasis and recurrence of colorectal cancer. PMID: 19341507 Ref: alpha2,6-hyposialylation of c-Met abolishes cell motility of ST6Gal-I-knockdown HCT116 cells. PMID: 19483716 Ref: Refractory response to growth factors impairs liver regeneration after hepatectomy in patients with viral hepatitis. PMID: 19760923 Ref: Tea catechins inhibit hepatocyte growth factor receptor (MET kinase) activity in human colon cancer cells: kinetic and molecular docking studies. PMID: 19839593 |
Ref: Effect of hepatocyte growth factor on progression of liver metastasis in colorectal cancer. PMID: 20422876 Ref: Demethylation of a LINE-1 antisense promoter in the cMet locus impairs Met signalling through induction of illegitimate transcription. PMID: 20562909 Ref: Clinical significance of aggressive hepatectomy for colorectal liver metastasis, evaluated from the HGF/c-Met pathway. PMID: 20596656 Ref: Sprouty-2 controls c-Met expression and metastatic potential of colon cancer cells: sprouty/c-Met upregulation in human colonic adenocarcinomas. PMID: 20661223 Ref: MET receptor sequence variants R970C and T992I lack transforming capacity. PMID: 20670955 Ref: Strategies for overcoming inherent and acquired resistance to EGFR inhibitors by targeting downstream effectors in the RAS/PI3K pathway. PMID: 20718704 |
Ref: GT-094, a NO-NSAID, inhibits colon cancer cell growth by activation of a reactive oxygen species-microRNA-27a: ZBTB10-specificity protein pathway. PMID: 21156786 Ref: Diosgenin suppresses hepatocyte growth factor (HGF)-induced epithelial-mesenchymal transition by down-regulation of Mdm2 and vimentin. PMID: 21504235 Ref: Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer? PMID: 21729677 Ref: NK4 gene expression enhances 5-fluorouracil-induced apoptosis of murine colon cancer cells. PMID: 21737644 Ref: Pharmacologic doses of ascorbic acid repress specificity protein (Sp) transcription factors and Sp-regulated genes in colon cancer cells. PMID: 21919647 Ref: [Expressions of MACC1, HGF, and C-met protein in epithelial ovarian cancer and their significance]. PMID: 21945764 Ref: Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma. PMID: 21955323 Ref: Coexpression of activated c-Met and death receptor 5 predicts better survival in colorectal carcinoma. PMID: 21978492 Ref: Over-expression of Metastasis-associated in Colon Cancer-1 (MACC1) Associates with Better Prognosis of Gastric Cancer Patients. PMID: 23483020 |
Ref: Evaluation of a multi-kinase inhibitor KRC-108 as an anti-tumor agent in vitro and in vivo. PMID: 21080208 Ref: Improving the clinical risk score: an analysis of molecular biomarkers in the era of modern chemotherapy for resectable hepatic colorectal cancer metastases. PMID: 21982065 Ref: Epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions in the colon. PMID: 22363130 Ref: Correlations between SUVmax and expression of GLUT1 and growth factors inducing lymphangiogenesis. PMID: 22444673 Ref: Expression of the hepatocyte growth factor and c-Met in colon cancer: correlation with clinicopathological features and overall survival. PMID: 22495710 Ref: KRAS mutant colorectal tumors: past and present. PMID: 22714415 Ref: Overexpression of metastasis-associated in colon cancer 1 predicts a poor outcome of hepatitis B virus-related hepatocellular carcinoma. PMID: 22736924 Ref: [Prognostic value of MACC1 and c-met expressions in non-small cell lung cancer]. PMID: 22814258 Ref: Induction of the stem-like cell regulator CD44 by Rho kinase inhibition contributes to the maintenance of colon cancer-initiating cells. PMID: 23002207 Ref: Multivariate analysis of molecular indicators for postoperative liver metastasis in colorectal cancer cases. PMID: 23098501 Ref: Aspirin inhibits colon cancer cell and tumor growth and downregulates specificity protein (Sp) transcription factors. PMID: 23110215 Ref: Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs. PMID: 23194063 |
Ref: Novel roles of liver sinusoidal endothelial cell lectin in colon carcinoma cell adhesion, migration and in-vivo metastasis to the liver. PMID: 22637699 Ref: FAK, CD44v6, c-Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk. PMID: 22733437 Ref: Extracellular signal-regulated kinase and Akt activation play a critical role in the process of hepatocyte growth factor-induced epithelial-mesenchymal transition. PMID: 23229794 Ref: Knockdown of MACC1 expression suppressed hepatocellular carcinoma cell migration and invasion and inhibited expression of MMP2 and MMP9. PMID: 23232575 Ref: Detection of miR-34a promoter methylation in combination with elevated expression of c-Met and beta-catenin predicts distant metastasis of colon cancer. PMID: 23243217 Ref: Increased growth of colorectal liver metastasis following partial hepatectomy. PMID: 23385555 Ref: High intratumoral metastasis-associated in colon cancer-1 expression predicts poor outcomes of cryoablation therapy for advanced hepatocellular carcinoma. PMID: 23414367 Ref: Study of critical role of c-Met and its inhibitor SU11274 in colorectal carcinoma. PMID: 23536000 Ref: Vascular endothelial growth factor receptors 1,3 and caveolin-1 are implicated in colorectal cancer aggressiveness and prognosis--correlations with epidermal growth factor receptor, CD44v6, focal adhesion kinase, and c-Met. PMID: 23580180 Ref: MACC1 mRNA levels predict cancer recurrence after resection of colorectal cancer liver metastases. PMID: 23665971 Ref: Dual inhibition of EGFR and c-Met kinase activation by MJ-56 reduces metastasis of HT29 human colorectal cancer cells. PMID: 23677180 Ref: Effect of c-Met inhibitor SU11274 on human colon cancer cell growth. PMID: 23876900 Ref: Integrating anti-EGFR therapies in metastatic colorectal cancer. PMID: 23997940 Ref: Role of cMET in the development and progression of colorectal cancer. PMID: 24005867 Ref: Multigene assays in metastatic colorectal cancer. PMID: 24158971 Ref: Proliferation of colorectal cancer is promoted by two signaling transduction expression patterns: ErbB2/ErbB3/AKT and MET/ErbB3/MAPK. PMID: 24205104 Ref: Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis. PMID: 24220141 |
Ref: Tumour growth stimulation following partial hepatectomy in mice is associated with increased upregulation of c-Met. PMID: 23900501 Ref: Decreased miR-340 expression in bone marrow is associated with liver metastasis of colorectal cancer. PMID: 24448820 Ref: A pharmacodynamic/pharmacokinetic study of ficlatuzumab in patients with advanced solid tumors and liver metastases. PMID: 24634378 Ref: Activation of c-Met and upregulation of CD44 expression are associated with the metastatic phenotype in the colorectal cancer liver metastasis model. PMID: 24823486 Ref: Clinical impact of c-MET expression and genetic mutational status in colorectal cancer patients after liver resection. PMID: 24863535 Ref: ADAM17-dependent c-MET-STAT3 signaling mediates resistance to MEK inhibitors in KRAS mutant colorectal cancer. PMID: 24931611 Ref: [Association of expression of HGF and its receptor c-Met to primary colorectal cancers with synchronous liver metastasis]. PMID: 24953371 Ref: MACC1 induces metastasis in ovarian carcinoma by upregulating hepatocyte growth factor receptor c-MET. PMID: 25009663 Ref: Activated cMET and IGF1R-driven PI3K signaling predicts poor survival in colorectal cancers independent of KRAS mutational status. PMID: 25090459 Ref: Tumor budding in colorectal carcinoma assessed by cytokeratin immunostaining and budding areas: possible involvement of c-Met. PMID: 25220207 Ref: c-Met targeting enhances the effect of irradiation and chemical agents against malignant colon cells harboring a KRAS mutation. PMID: 25427200 |
Ref: An exploratory biomarker study in metastatic tumors from colorectal cancer patients treated with bevacizumab. PMID: 24980447 Ref: Potent antitumor activity of cabozantinib, a c-MET and VEGFR2 inhibitor, in a colorectal cancer patient-derived tumor explant model. PMID: 25242168 Ref: Tumour budding is associated with hypoxia at the advancing front of colorectal cancer. PMID: 25381897 Ref: Selective bispecific T cell recruiting antibody and antitumor activity of adoptive T cell transfer. PMID: 25424197 Ref: Metastasis-associated in colon cancer-1 upregulates vascular endothelial growth factor-C/D to promote lymphangiogenesis in human gastric cancer. PMID: 25444928 Ref: The c-MET/PI3K signaling is associated with cancer resistance to doxorubicin and photodynamic therapy by elevating BCRP/ABCG2 expression. PMID: 25534417 Ref: High c-Met expression is a negative prognostic marker for colorectal cancer: a meta-analysis. PMID: 25636446 Ref: HDAC Inhibition Overcomes Acute Resistance to MEK Inhibition in BRAF-Mutant Colorectal Cancer by Downregulation of c-FLIPL. PMID: 25813020 Ref: Prognostic value of c-Met in colorectal cancer: a meta-analysis. PMID: 25834339 Ref: YKL-40/c-Met expression in rectal cancer biopsies predicts tumor regression following neoadjuvant chemoradiotherapy: a multi-institutional study. PMID: 25875173 Ref: Tumour pharmacodynamics and circulating cell free DNA in patients with refractory colorectal carcinoma treated with regorafenib. PMID: 25889309 Ref: Metastasis-associated in colon cancer-1 promotes vasculogenic mimicry in gastric cancer by upregulating TWIST1/2. PMID: 25895023 Ref: Current and Future Approaches to Target the Epidermal Growth Factor Receptor and Its Downstream Signaling in Metastatic Colorectal Cancer. PMID: 26077270 Ref: Overexpression of MACC1 and the association with hepatocyte growth factor/c-Met in epithelial ovarian cancer. PMID: 26137000 Ref: Detection of colorectal polyps in humans using an intravenously administered fluorescent peptide targeted against c-Met. PMID: 26168295 Ref: Cabozantinib, a Novel c-Met Inhibitor, Inhibits Colorectal Cancer Development in a Xenograft Model. PMID: 26255947 Ref: c-MET immunostaining in colorectal carcinoma is associated with local disease recurrence. PMID: 26459369 Ref: Molecular profiling of 6,892 colorectal cancer samples suggests different possible treatment options specific to metastatic sites. PMID: 26553611 Ref: c-MET expression in colorectal adenomas and primary carcinomas with its corresponding metastases. PMID: 26697193 |
Ref: LoVo colon cancer cells resistant to oxaliplatin overexpress c-MET and VEGFR-1 and respond to VEGF with dephosphorylation of c-MET. PMID: 25647613 Ref: Clinical impact of c-MET expression and mutational status in patients with colorectal cancer lung metastases. PMID: 26503729 Ref: Nanoproteomic analysis of ischemia-dependent changes in signaling protein phosphorylation in colorectal normal and cancer tissue. PMID: 26742633 Ref: Expression of hepatocyte growth factor and c-Met is characteristic of alpha-fetoprotein-producing colorectal adenocarcinoma: A report of three cases. PMID: 26870275 Ref: Curcumin mediates reversion of HGF-induced epithelial-mesenchymal transition via inhibition of c-Met expression in DU145 cells. PMID: 26893768 Ref: Development of a Novel c-MET-Based CTC Detection Platform. PMID: 26951228 Ref: c-MET inhibition enhances the response of the colorectal cancer cells to irradiation in vitro and in vivo. PMID: 27073569 Ref: IGF1R and c-met as therapeutic targets for colorectal cancer. PMID: 27470393 Ref: Voltage-gated sodium channel Nav 1.7 promotes gastric cancer progression through MACC1-mediated upregulation of NHE1. PMID: 27529686 Ref: Transcriptional upregulation of c-MET is associated with invasion and tumor budding in colorectal cancer. PMID: 27793046 |
Ref: Norcantharidin Inhibits cell growth by suppressing the expression and phosphorylation of both EGFR and c-Met in human colon cancer cells. PMID: 28086832 Ref: Isolation and characterization of anti c-met single chain fragment variable (scFv) antibodies. PMID: 28090795 Ref: Naturally occurring InlB variants that support intragastric Listeria monocytogenes infection in mice. PMID: 28104777 Ref: Caspase-mediated proteolysis of the sorting nexin 2 disrupts retromer assembly and potentiates Met/hepatocyte growth factor receptor signaling. PMID: 28179995 Ref: Mecp2-mediated Epigenetic Silencing of miR-137 Contributes to Colorectal Adenoma-Carcinoma Sequence and Tumor Progression via Relieving the Suppression of c-Met. PMID: 28291253 Ref: The c-Met receptor: Implication for targeted therapies in colorectal cancer. PMID: 28459362 Ref: mTORC1-independent autophagy regulates receptor tyrosine kinase phosphorylation in colorectal cancer cells via an mTORC2-mediated mechanism. PMID: 28475179 Ref: YB-1 regulates tumor growth by promoting MACC1/c-Met pathway in human lung adenocarcinoma. PMID: 28624808 Ref: Target identification, lead optimization and antitumor evaluation of some new 1,2,4-triazines as c-Met kinase inhibitors. PMID: 28715754 Ref: miR-141 Inhibits Proliferation and Migration of Colorectal Cancer SW480 Cells. PMID: 28739727 Ref: Andrographolide enhanced 5-fluorouracil-induced antitumor effect in colorectal cancer via inhibition of c-MET pathway. PMID: 29200829 Ref: A five-gene based risk score with high prognostic value in colorectal cancer. PMID: 29344121 |
Ref: Effects of PHA-665752 and Cetuximab Combination Treatment on In Vitro and Murine Xenograft Growth of Human Colorectal Cancer Cells with KRAS or BRAF Mutations. PMID: 28359236 Ref: miR-146a targets c-met and abolishes colorectal cancer liver metastasis. PMID: 29133238 Ref: Effective Timing of Surgical Resection of Colorectal Cancer Liver Metastases During Chemotherapy. PMID: 29374697 Ref: Long Noncoding RNA GAPLINC Promotes Cells Migration and Invasion in Colorectal Cancer Cell by Regulating miR-34a/c-MET Signal Pathway. PMID: 29427222 Ref: MACC1 and HGF are associated with survival in patients with gastric cancer. PMID: 29435059 Ref: Effects of PHA-665752 and vemurafenib combination treatment on in vitro and murine xenograft growth of human colorectal cancer cells with BRAF(V600E) mutations. PMID: 29456739 Ref: Association of differential miRNA expression with hepatic vs. peritoneal metastatic spread in colorectal cancer. PMID: 29463215 Ref: Phase I Trial of Anti-MET Monoclonal Antibody in MET-Overexpressed Refractory Cancer. PMID: 29551559 Ref: c-MET Overexpression in Colorectal Cancer: A Poor Prognostic Factor for Survival. PMID: 29576428 Ref: Coexistence of MACC1 and NM23-H1 dysregulation and tumor budding promise early prognostic evidence for recurrence risk of early-stage colon cancer. PMID: 29700912 Ref: Association Between c-Met and Lymphangiogenic Factors in Patients With Colorectal Cancer. PMID: 29742856 Ref: Inhibiting focal adhesion kinase: A potential target for enhancing therapeutic efficacy in colorectal cancer therapy. PMID: 30364839 |